Candel Therapeutics Announces Participation in Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

NEXT STORY
NextCure Announces New Appointments to its Board of Directors
PREV STORY
Arch Therapeutics Launches Coverage and Reimbursement Pilot
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chiesi Group Announces Establishment of New Global Rare Diseases Division

author_avatar
NASDAQ Market News

Immunocore presents Phase 2 tebentafusp clinical results at ESMO Immuno-Oncology Virtual Congress 2020

author_avatar
NASDAQ Market News

Coherus and Junshi Biosciences Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News